Mepolizumab subcutaneous (SC) vs placebo
Rate of exacerbations requiring emergency department treatment or admission · people with asthma
Mepolizumab subcutaneous (SC) leads to lower rate of exacerbations requiring emergency department treatment or… compared with placebo (high certainty).
1 finding from 1 review
- Rate ratio 0.36 [0.2, 0.66]2 studies · 936 participantsHigh